UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2020

 

Commission File Number 000-56026

 

TODOS MEDICAL LTD.

(Translation of registrant’s name into English)

 

1 Hamada Street

Rehovot, Israel 2244427

Tel: (011) (972) 8-633-3964

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

  [X] Form 20-F   [  ] Form 40-F  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

 

 

     

 

 

TODOS MEDICAL LTD.

 

EXPLANATORY NOTE

 

On April 24, 2020, Todos Medical USA, Inc., a subsidiary of the Company (“Todos”), entered into the Amended and Restated Collaboration Agreement with Emerald Organic Products, Inc.(“Emerald”) pursuant to which Todos became the owner of 100% of the equity of Corona Diagnostics, LLC and agreed to integrate its COVID-19 tests with Emerald’s telemedicine (Carie Health, Inc.) and independent pharmacy business Bonsa Health, Inc. to create a full solution to help facilitate the screening and diagnosis of individuals potentially to identify each indiciation’s COVID-19 PCR and/or antibody testing status to facilitate return to work programs in the United States.

 

This report on Form 6-K (including the exhibits hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

EXHIBITS

 

Exhibit

Number

  Description
     
99.1  

Amended and Restated Collaboration Agreement between Todos Medical USA, Inc. and Emerald Organic Products, Inc. dated April 24, 2020

 

  -2-  

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  TODOS MEDICAL LTD.  
   
  By: /s/ Gerald Commissiong
  Name: Gerald Commissiong
  Title: Chief Executive Officer
     
Date: May 8, 2020    

 

  -3-  

 

Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From Mar 2024 to May 2024 Click Here for more Todos Med (CE) Charts.
Todos Med (CE) (USOTC:TOMDF)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Todos Med (CE) Charts.